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Letters to the Editor 85Although multidrug resistance has commonly been
reported in nosocomial P. aeruginosa, community-acquired
data are less frequently reported. For this reason, epidemio-
logical studies on the prevalence and antimicrobial suscept-
ibility patterns of resistant isolates in different geographical
settings, would provide useful information for both empirical
treatment of suspected infections and better management of
patients.
Our results show that in our setting imipenem is still very
active against strains of P. aeruginosa in pediatric infections,
although other studies have reported higher resistance
rates.3,4 Recent studies have reduced safety concerns over
the use of quinolones in pediatric patients. Combined with
the good antimicrobial activity shown in this and other
studies,5 this makes them a good empirical choice for
community-acquired infections. Local surveillance of
antimicrobial activity should be done periodically to guide
antimicrobial therapy, especially as carbapenem-resistant
P. aeruginosa has been reported as an emerging problem in
Latin America.6
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an HIV-infected infant exposed to nucleoside
reverse transcriptase inhibitors
Nucleoside analogue reverse transcriptase inhibitors (NRTIs)
inhibit mitochondrial DNA (mtDNA) polymerase gamma
thereby interfering with mtDNA replication.1—3 The relative
potency of the NRTIs in causing mitochondrial dysfunction is
highest for zalcitabine, followed by didanosine, stavudine,
and zidovudine. Lamivudine, abacavir, and tenofovir have
lower affinity for mtDNA polymerase.4 In utero and perinatal
exposure to NRTIs are known to cause hyperlactatemia (HLA)
from mitochondrial toxicity.5,6
An HIV-infected mother detected at 30 weeks of preg-
nancy was treated with lamivudine, stavudine, and nevira-
pine. A live male baby weighing 2135 g was delivered by
elective cesarean section at 38 weeks of gestation with
intrapartum intravenous zidovudine cover as per PACTG076 protocol.7 He was discharged well with oral zidovudine
on the third day.
At three weeks old he developed fever, abdominal dis-
tension, diarrhea, and vomiting, which required treatment
with intravenous fluids and antibiotics, and was discharged
well after 12 days. At five weeks old he returned with
diarrhea, poor feeding, dehydration, and acidotic breathing.
Arterial blood pH was 7.13, pO2 128 mmHg, pCO2 18.7 mmHg,
base excess 21.9 mmol/L, and anion gap 24 mmol/L.
Serum lactate and ammonia levels were 4.07 mmol/L and
203.6 mmol/L, respectively. Serum aspartate aminotransfer-
ase (AST), alanine aminotransferase (ALT), and gamma glu-
tamyltransferase (GGT) levels were 89, 189, and 166 IU/L,
respectively. Serum albumin was 28 g/L with prolonged acti-
vated partial thromboplastin time (APTT) and increased
prothrombin time (PT) ratio. Repeated hemoculture and
stool cultures did not yield any pathogen. His urine was
screened for inborn errors of metabolism but proved normal.
On the second hospital day he developed jerking movements
86 Letters to the Editorinvolving the right arm. A computed tomography scan of the
brain was normal and meningitis excluded with cerebrospinal
fluid examination. Zidovudine was stopped and his clinical
condition improved. HIV infection had been confirmed by
HIV-DNA PCR tests carried out earlier. At seven weeks old
his serum lactate was 2.69 mmol/L and ammonia was
59.4 mmol/L. The serum ALT and AST levels had normalized
to 31 and 27 IU/L, respectively, while the GGT level remained
high at 413 IU/L. He was asymptomatic but had moderate
global developmental delay.
The clinical features of HLA can be very variable and non-
specific, with initial symptoms such as generalized fatigue,
muscle weakness, myalgia, gastrointestinal symptoms
(nausea, vomiting, diarrhea, abdominal pain, hepatomegaly,
anorexia), respiratory involvement (tachypnea and dys-
pnea), or even neurological symptoms (motor weakness
and Guillain—Barre-like syndrome).8 Hepatic dysfunction
may present with encephalopathy with raised liver enzymes
but jaundice is unusual.9 In retrospect the infant had symp-
tomatic HLA at three weeks old, which was unrecognized.
Liver dysfunction was evident with elevated liver enzymes
and coagulopathy. The seizure was probably due to hepatic
encephalopathy complicated by delayed development.
The relative roles of in utero exposure to stavudine and
lamivudine and perinatal exposure to zidovudine in causing
the severe HLA are unknown; so was the role of HIV infection.
Nevertheless, this has posed a challenge in the choice of
antiretrovirals for therapy, as the number of available NRTIs
less likely to cause HLA is limited.
Conflict of interest: No conflict of interest to declare.
References
1. Brinkman K, Hofstede HJM, Burger DM, et al. Adverse effects of
reverse transcriptase inhibitors: mitochondrial toxicity as com-
mon pathway. AIDS 1998;12:1735—44.
2. Simpson MV, Chin CD, Keilbaugh SA, Lin TS, Prusoff WH. Studies on
the inhibition of mitochondrial DNA replication by 30-azido-30-
deoxythymidine and other dideoxynucleoside analogs which inhi-
bit HIV-1 replication. Biochem Pharmacol 1989;38:1033—6.3. Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin
JL. Mitochondrial myopathy caused by long-term zidovudine
therapy. N Engl J Med 1990;322:1098—105.
4. Birkus G, Hitchcock MJ, Cihlar T. Assessment of mitochondrial
toxicity in human cells treated with tenofovir: comparison with
other nucleoside reverse transcriptase inhibitors. Antimicrob
Agents Chemother 2002;46:716—23.
5. Alimenti A, Burdge DR, Ogilvie GS, Money DM, Forbes JC. Lactic
acidemia in human immunodeficiency virus-uninfected infants
exposed to perinatal antiretroviral therapy. Ped Infect Dis J
2003;22:782—8.
6. Blanche S, Tardieu M, Rustin P. Persistent mitochondrial dys-
function and perinatal exposure to antiretroviral nucleoside
analogues. Lancet 1999;354:1084—9.
7. Connor EM, Sperling RS, Gelber R, et al. Reduction of mater-
nal—infant transmission of human immunodeficiency virus
type 1 with zidovudine treatment. N Engl J Med 1994;331:
1173—80.
8. Shah SS, Rodriguez T, McGowan JP. Miller Fisher variant of Guil-
lain—Barre syndrome associatedwith lactic acidosis and stavudine
therapy. Clin Infect Dis 2003;36:e131—3.
9. Schambelan M, Benson CA, Carr A, et al. Management of meta-
bolic complications associated with antiretroviral therapy for
HIV-1infection: recommendations of an International AIDS
Society-USA panel. J Acquir Immune Defic Syndr 2002;31:
257—75.
Mia-Tuang Koh*
Department of Paediatrics,
University of Malaya, 59100 Kuala Lumpur,
Malaysia
*Tel.: +60 3 79492065; fax: +60 3 79556114
E-mail address: kohmt@um.edu.my
Corresponding Editor: Salim S. Abdool Karim,
Durban, South Africa
13 October 2005
doi:10.1016/j.ijid.2006.02.001Klebsiella ozaenae splenic abscess
following odontogenic infection in
a girl with sickle cell disease
Hematogenous spread of oral colonizers after dental extrac-
tion and dental manipulation is a well recognized pro-
blem.1,2 I report herein a case of splenic abscess and
bacteremia due to Klebsiella ozaenae following an odonto-
genic infection.
A 16-year old girl with sickle-beta-thalassemia was hos-
pitalized with a 10-day history of tooth pain and swelling of
the cheek. On examination, she was toxic, febrile, and
hypotensive with a carious, tender right lower first molar
tooth. Purulent exudate was found at the gingival sulcus.
Tender submandibular lymphadenopathy, diffuse swelling
over the right lower face, and trismus were noted. Four days
earlier she had received amoxicillin and aspirin with norelief. Her hemoglobin was 8.8 g/dL and total white cell
count was 13.4  109/L (94% polymorphs; 11% bands).
Radiographic examination revealed pulpitis, periapical
infection of the right lower first molar tooth, and an adja-
cent dentoalveolar abscess. After submitting blood and
aspirated pus samples collected from the abscess for cul-
ture, treatment with penicillin, chloramphenicol, metroni-
dazole, intravenous fluids, sodium bicarbonate, and
analgesics was initiated. On day 3, dental extraction was
done and aseptically sampled material from the pulp cham-
ber was submitted for culture. Blood and pus culture speci-
mens yielded a lactose non-fermenting, catalase-positive,
facultative Gram-negative bacillus on blood and MacConkey
agar. The organism was identified as Klebsiella ozaenae and
differentiated from other species by its ability to produce a
positive methyl red test, o-nitrophenyl-b-D-galactopyrano-
side (ONPG), production of citrate, inability to ferment
dulcitol and produce malonate.2—5 The antimicrobial
